A Study of Safety and Drug Levels of HIB210 in Healthy Volunteers
Completed · Phase 1 · Has a placebo group
Conditions studied: Immune System Diseases, Autoimmunity
In brief
The goal of this clinical trial is to test safety of the investigational product in healthy volunteers. The main questions it aims to answer is when HIB210 is administered as multiple doses, is it: 1. Safe 2. Well tolerated 3. Does the body absorb and eliminate HIB210 as expected
Key facts
- Study ID
- NCT05928585
- Run by
- HI-Bio, A Biogen Company
- People needed
- 30
- Starts
- 2023-07-06
- Expected to finish
- 2024-06-10
- Last updated by the study team
- 2025-02-07
Who can join
Age: 19 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- HI-Bio Investigational Site — Hialeah, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.